Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with relevant stakeholders on the finding of the AffiDX antigen lateral flow covid-19 test small-scale study that that test outperformed two lateral flow antigen tests which are commercially available in Europe when detecting the Delta variant of the SARS-CoV-2.
We have had no such discussions.